Senior insider sale
Chief Executive Officer at APOGEE THERAPEUTICS, INC. — senior position signals high conviction
$9.97M
140K shares
What this filing means
HENDERSON MICHAEL THOMAS plans to sell 140K shares of APOGEE THERAPEUTICS, INC. valued at approximately $9.97M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/11/2026ACC: 0001949846-26-000059
DirectorOfficer· Chief Executive Officer
Since Feb 2026
140K
Shares to sell
$9.97M
Approx. market value
60K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
RSU VESTING PER FOLLOWING DATES: 06/02/23 thru 12/14/23
NA
6/2/2023
60KTotal acquired60K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/2/2023 | RSU VESTING PER FOLLOWING DATES: 06/02/23 thru 12/14/23 NA | 60K | — |
| Total | 60K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
20K
Market value
$1.62M
1/14/2026
—Completed
Units to sell
20K
Market value
$1.51M
12/10/2025
—Completed
Units to sell
40K
Market value
$3.00M
12/4/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
60K
Market value
$3.84M
2/11/2026
Total
Units
140K
Value
$9.97M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
1/14/2026 | 20K | $1.62M | — | Completed |
12/10/2025 | 20K | $1.51M | — | Completed |
12/4/2025 | 40K | $3.00M | — | Completed |
| Planned — Approximate Date | ||||
2/11/2026 | 60K | $3.84M | NASDAQ | Planned |
| Total | 140K | $9.97M | ||